Literature DB >> 2478466

Phosphorylation of myelin basic protein in intact oligodendrocytes: inhibition by galactosylsphingosine and cyclic AMP.

T Vartanian1, G Dawson, B Soliven, D J Nelson, S Szuchet.   

Abstract

We have previously shown that cyclic AMP (cAMP) inhibits the protein kinase C (PKC)-mediated phosphorylation of myelin basic protein (MBP) in cultured oligodendrocytes (OLGs). Recently, it has been demonstrated that the long chain base sphingosine inhibits PKC by competing PKC effectors (diacylglycerol and phorbol esters) for a binding site on the kinase (Hannun and Bell: Science 235: 670-674, 1987). In this report we define further the mechanism by which cAMP inhibits MBP phosphorylation by comparing the effects of cAMP with that of galactosylsphingosine (psychosine), a potential catabolite of galactocerebroside, the major OLG glycosphingolipid. We identify the consequences of psychosine treatment and PKC down-regulation on OLG morphology and electrophysiology and discuss their relevance. Our results in intact ovine oligodendrocytes are consistent with a mechanism in which cAMP inhibits MBP phosphorylation by interfering with the release of diacylglycerol (DAG) from phosphatidylinositol. First, the effects of cAMP on MBP phosphorylation are reversed with exogenous TPA; and second, cAMP inhibits the incorporation of 1-[14C]arachidonate into DAG and specifically inhibits the turnover (as judged by 32PO4 3-incorporation) of phosphatidylinositol. Psychosine inhibits MBP phosphorylation, and its action can be reversed by TPA suggesting a mechanism of inhibition similar to that described for other systems. In addition, psychosine has profound effects on OLG morphology; it disintegrates OLG processes while leaving the cell soma intact. Stable hyperpolarized resting potentials were obtained following psychosine treatment, but there was a 66% decrease in membrane capacitance indicating a significant decrement in membrane surface area. The morphological changes induced by psychosine are reversible and can be eliminated by removing the drug but not by the addition of TPA. Whether inhibition of PKC by psychosine plays any role in process dissolution remains an unanswered question. However, current evidence suggests that a PKC-independent mechanism may be at play. This investigation in conjunction with our previous work emphasizes a role for the interregulation of protein kinase A (PKA) and PKC in the control of OLG somal vs. myelin components. This may have significant implications for central nervous system myelin assembly.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2478466     DOI: 10.1002/glia.440020509

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  7 in total

Review 1.  Lysosphingolipids and sphingolipidoses: Psychosine in Krabbe's disease.

Authors:  Stefka Spassieva; Erhard Bieberich
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

2.  Tumor necrosis factor inhibits K+ current expression in cultured oligodendrocytes.

Authors:  B Soliven; S Szuchet; D J Nelson
Journal:  J Membr Biol       Date:  1991-11       Impact factor: 1.843

3.  Neurons and oligodendrocytes recycle sphingosine 1-phosphate to ceramide: significance for apoptosis and multiple sclerosis.

Authors:  Jingdong Qin; Evgeny Berdyshev; Jonathan Goya; Viswanathan Natarajan; Glyn Dawson
Journal:  J Biol Chem       Date:  2010-03-09       Impact factor: 5.157

Review 4.  Signaling and regulatory functions of bioactive sphingolipids as therapeutic targets in multiple sclerosis.

Authors:  Maria Podbielska; Hubert Krotkiewski; Edward L Hogan
Journal:  Neurochem Res       Date:  2012-03-27       Impact factor: 3.996

5.  Physicochemical characterization of psychosine by 1H nuclear magnetic resonance and electron microscopy.

Authors:  L Orfi; C K Larive; S M LeVine
Journal:  Lipids       Date:  1997-10       Impact factor: 1.880

6.  Accumulation of galactosylsphingosine (psychosine) does not interfere with phosphorylation and methylation of myelin basic protein in the twitcher mouse.

Authors:  T Yoshimura; T Kobayashi; N Shinnoh; I Goto
Journal:  Neurochem Res       Date:  1990-10       Impact factor: 3.996

7.  Lysosomal Re-acidification Prevents Lysosphingolipid-Induced Lysosomal Impairment and Cellular Toxicity.

Authors:  Christopher J Folts; Nicole Scott-Hewitt; Christoph Pröschel; Margot Mayer-Pröschel; Mark Noble
Journal:  PLoS Biol       Date:  2016-12-15       Impact factor: 8.029

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.